Microbial synthesis of 2,6-diaminopurine nucleosides
2,6-Diaminopurine nucleosides are used as pharmaceutical drugs or prodrugs against cancer and viral diseases. The synthesis of 2,6-diaminopurine riboside, -2′-deoxyriboside, -2′,3′-dideoxyriboside and -arabinofuranoside was efficiently carried out by transglycosylation using bacterial whole cells as...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_13811177_v39_n1-4_p40_Medici |
Aporte de: |
id |
todo:paper_13811177_v39_n1-4_p40_Medici |
---|---|
record_format |
dspace |
spelling |
todo:paper_13811177_v39_n1-4_p40_Medici2023-10-03T16:11:44Z Microbial synthesis of 2,6-diaminopurine nucleosides Médici, R. Lewkowicz, E.S. Iribarren, A.M. 2,6-Diaminopurine nucleoside Microbial transglycosylation Nucleoside analogues Whole cells Bacteria Biocatalysts Derivatives Diseases Drug products Synthesis (chemical) Microbial transglycosylation Nucleoside analogues Nucleosides Whole cells Nitrogen compounds 2 aminoadenosine 2' deoxyriboside 2',3' dideoxyriboside arabinofuranoside nucleoside derivative unclassified drug Achromobacter Aeromonas Arthrobacter article Bacillus bacterial cell biocatalyst Brevibacterium Cellulomonas Citrobacter Corynebacterium drug synthesis Enterobacter Erwinia Escherichia coli glycosylation Klebsiella Micrococcus nonhuman Proteus Pseudomonas Rhizobium Serratia Staphylococcus whole cell Xanthomonas Achromobacter Aeromonas Arthrobacter Bacillus (bacterium) Bacteria (microorganisms) Brevibacterium Cellulomonas Citrobacter Corynebacterium Enterobacter Erwinia Escherichia coli Klebsiella Micrococcus Proteus (enterobacteria) Pseudomonas Rhizobium Serratia Staphylococcus Xanthomonas 2,6-Diaminopurine nucleosides are used as pharmaceutical drugs or prodrugs against cancer and viral diseases. The synthesis of 2,6-diaminopurine riboside, -2′-deoxyriboside, -2′,3′-dideoxyriboside and -arabinofuranoside was efficiently carried out by transglycosylation using bacterial whole cells as biocatalysts. The preparation of 2,6-diaminopurine-2′,3′-dideoxyriboside catalysed by whole cells is here reported for the first time. © 2006 Elsevier B.V. All rights reserved. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_13811177_v39_n1-4_p40_Medici |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
2,6-Diaminopurine nucleoside Microbial transglycosylation Nucleoside analogues Whole cells Bacteria Biocatalysts Derivatives Diseases Drug products Synthesis (chemical) Microbial transglycosylation Nucleoside analogues Nucleosides Whole cells Nitrogen compounds 2 aminoadenosine 2' deoxyriboside 2',3' dideoxyriboside arabinofuranoside nucleoside derivative unclassified drug Achromobacter Aeromonas Arthrobacter article Bacillus bacterial cell biocatalyst Brevibacterium Cellulomonas Citrobacter Corynebacterium drug synthesis Enterobacter Erwinia Escherichia coli glycosylation Klebsiella Micrococcus nonhuman Proteus Pseudomonas Rhizobium Serratia Staphylococcus whole cell Xanthomonas Achromobacter Aeromonas Arthrobacter Bacillus (bacterium) Bacteria (microorganisms) Brevibacterium Cellulomonas Citrobacter Corynebacterium Enterobacter Erwinia Escherichia coli Klebsiella Micrococcus Proteus (enterobacteria) Pseudomonas Rhizobium Serratia Staphylococcus Xanthomonas |
spellingShingle |
2,6-Diaminopurine nucleoside Microbial transglycosylation Nucleoside analogues Whole cells Bacteria Biocatalysts Derivatives Diseases Drug products Synthesis (chemical) Microbial transglycosylation Nucleoside analogues Nucleosides Whole cells Nitrogen compounds 2 aminoadenosine 2' deoxyriboside 2',3' dideoxyriboside arabinofuranoside nucleoside derivative unclassified drug Achromobacter Aeromonas Arthrobacter article Bacillus bacterial cell biocatalyst Brevibacterium Cellulomonas Citrobacter Corynebacterium drug synthesis Enterobacter Erwinia Escherichia coli glycosylation Klebsiella Micrococcus nonhuman Proteus Pseudomonas Rhizobium Serratia Staphylococcus whole cell Xanthomonas Achromobacter Aeromonas Arthrobacter Bacillus (bacterium) Bacteria (microorganisms) Brevibacterium Cellulomonas Citrobacter Corynebacterium Enterobacter Erwinia Escherichia coli Klebsiella Micrococcus Proteus (enterobacteria) Pseudomonas Rhizobium Serratia Staphylococcus Xanthomonas Médici, R. Lewkowicz, E.S. Iribarren, A.M. Microbial synthesis of 2,6-diaminopurine nucleosides |
topic_facet |
2,6-Diaminopurine nucleoside Microbial transglycosylation Nucleoside analogues Whole cells Bacteria Biocatalysts Derivatives Diseases Drug products Synthesis (chemical) Microbial transglycosylation Nucleoside analogues Nucleosides Whole cells Nitrogen compounds 2 aminoadenosine 2' deoxyriboside 2',3' dideoxyriboside arabinofuranoside nucleoside derivative unclassified drug Achromobacter Aeromonas Arthrobacter article Bacillus bacterial cell biocatalyst Brevibacterium Cellulomonas Citrobacter Corynebacterium drug synthesis Enterobacter Erwinia Escherichia coli glycosylation Klebsiella Micrococcus nonhuman Proteus Pseudomonas Rhizobium Serratia Staphylococcus whole cell Xanthomonas Achromobacter Aeromonas Arthrobacter Bacillus (bacterium) Bacteria (microorganisms) Brevibacterium Cellulomonas Citrobacter Corynebacterium Enterobacter Erwinia Escherichia coli Klebsiella Micrococcus Proteus (enterobacteria) Pseudomonas Rhizobium Serratia Staphylococcus Xanthomonas |
description |
2,6-Diaminopurine nucleosides are used as pharmaceutical drugs or prodrugs against cancer and viral diseases. The synthesis of 2,6-diaminopurine riboside, -2′-deoxyriboside, -2′,3′-dideoxyriboside and -arabinofuranoside was efficiently carried out by transglycosylation using bacterial whole cells as biocatalysts. The preparation of 2,6-diaminopurine-2′,3′-dideoxyriboside catalysed by whole cells is here reported for the first time. © 2006 Elsevier B.V. All rights reserved. |
format |
JOUR |
author |
Médici, R. Lewkowicz, E.S. Iribarren, A.M. |
author_facet |
Médici, R. Lewkowicz, E.S. Iribarren, A.M. |
author_sort |
Médici, R. |
title |
Microbial synthesis of 2,6-diaminopurine nucleosides |
title_short |
Microbial synthesis of 2,6-diaminopurine nucleosides |
title_full |
Microbial synthesis of 2,6-diaminopurine nucleosides |
title_fullStr |
Microbial synthesis of 2,6-diaminopurine nucleosides |
title_full_unstemmed |
Microbial synthesis of 2,6-diaminopurine nucleosides |
title_sort |
microbial synthesis of 2,6-diaminopurine nucleosides |
url |
http://hdl.handle.net/20.500.12110/paper_13811177_v39_n1-4_p40_Medici |
work_keys_str_mv |
AT medicir microbialsynthesisof26diaminopurinenucleosides AT lewkowiczes microbialsynthesisof26diaminopurinenucleosides AT iribarrenam microbialsynthesisof26diaminopurinenucleosides |
_version_ |
1782030944470827008 |